Status:
COMPLETED
A Study of Abicipar Pegol in Patients With Diabetic Macular Edema
Lead Sponsor:
Allergan
Conditions:
Macular Edema
Eligibility:
All Genders
19+ years
Phase:
PHASE2
Brief Summary
This is a safety and efficacy study of abicipar pegol in patients with diabetic macular edema.
Eligibility Criteria
Inclusion
- Diagnosis of diabetes mellitus (Type 1 or 2)
- Decreased vision due to diabetic macular edema in at least 1 eye
- Best corrected visual acuity of 20/32 to 20/320 in the study eye and 20/200 or better in the fellow eye
Exclusion
- Stroke or heart attack within the past 3 months
- History of vitrectomy, macular surgery, or glaucoma surgery in the study eye
- Cataract or refractive surgery in the study eye within the last 3 months
- Laser photocoagulation of the study eye within the last 3 months
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
151 Patients enrolled
Trial Details
Trial ID
NCT02186119
Start Date
July 1 2014
End Date
June 1 2015
Last Update
July 14 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Gilbert, Arizona, United States
2
Abilene, Texas, United States